• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

除细胞色素P450外的人类I相代谢酶和II相代谢酶的组织特异性mRNA表达谱。

Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes.

作者信息

Nishimura Masuhiro, Naito Shinsaku

机构信息

Division of Pharmacology, Drug Safety and Metabolism, Otsuka Pharmaceutical Factory Inc, Naruto, Tokushima, Japan.

出版信息

Drug Metab Pharmacokinet. 2006 Oct;21(5):357-74. doi: 10.2133/dmpk.21.357.

DOI:10.2133/dmpk.21.357
PMID:17072089
Abstract

Pairs of forward and reverse primers and TaqMan probes specific to each of 52 human phase I metabolizing enzymes (alcohol dehydrogenase, aldehyde dehydrogenase, aldehyde oxidase, dihydropyrimidine dehydrogenase, epoxide hydrolase, esterase, flavin-containing monooxygenase, monoamine oxidase, prostaglandin endoperoxide synthase, quinone oxidoreductase, and xanthene dehydrogenase) and 48 human phase II metabolizing enzymes (acetyltransferase, acyl-CoA:amino acid N-acyltransferase, UDP-glucuronosyltransferase, glutathione S-transferase, methyltransferase, and sulfotransferase) were prepared. The mRNA expression level of each target enzyme was analyzed in total RNA from single and pooled specimens of various human tissues (adrenal gland, bone marrow, brain, colon, heart, kidney, liver, lung, pancreas, peripheral leukocytes, placenta, prostate, salivary gland, skeletal muscle, small intestine, spinal cord, spleen, stomach, testis, thymus, thyroid gland, trachea, and uterus) by real-time reverse transcription PCR using an ABI PRISM 7700 Sequence Detection System. Further, individual differences in the mRNA expression of representative human phase I and II metabolizing enzymes in the liver were also evaluated. The mRNA expression profiles of the above phase I and phase II metabolizing enzymes in 23 different human tissues were used to identify the tissues exhibiting high transcriptional activity for these enzymes. These results are expected to be valuable in establishing drug metabolism-mediated screening systems for new chemical entities in new drug development and in research concerning the clinical diagnosis of disease.

摘要

制备了针对52种人类I相代谢酶(乙醇脱氢酶、醛脱氢酶、醛氧化酶、二氢嘧啶脱氢酶、环氧化物水解酶、酯酶、含黄素单加氧酶、单胺氧化酶、前列腺素内过氧化物合酶、醌氧化还原酶和黄嘌呤脱氢酶)和48种人类II相代谢酶(乙酰基转移酶、酰基辅酶A:氨基酸N-酰基转移酶、尿苷二磷酸葡萄糖醛酸基转移酶、谷胱甘肽S-转移酶、甲基转移酶和磺基转移酶)的正向和反向引物对以及TaqMan探针。使用ABI PRISM 7700序列检测系统,通过实时逆转录PCR分析了来自各种人类组织(肾上腺、骨髓、脑、结肠、心脏、肾脏、肝脏、肺、胰腺、外周血白细胞、胎盘、前列腺、唾液腺、骨骼肌、小肠、脊髓、脾脏、胃、睾丸、胸腺、甲状腺、气管和子宫)的单个和混合样本的总RNA中各目标酶的mRNA表达水平。此外,还评估了肝脏中代表性人类I相和II相代谢酶mRNA表达的个体差异。利用上述I相和II相代谢酶在23种不同人类组织中的mRNA表达谱来鉴定这些酶具有高转录活性的组织。这些结果有望在建立新药开发中新型化学实体的药物代谢介导的筛选系统以及疾病临床诊断研究中具有重要价值。

相似文献

1
Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes.除细胞色素P450外的人类I相代谢酶和II相代谢酶的组织特异性mRNA表达谱。
Drug Metab Pharmacokinet. 2006 Oct;21(5):357-74. doi: 10.2133/dmpk.21.357.
2
Tissue-specific mRNA expression profiles of human carbohydrate sulfotransferase and tyrosylprotein sulfotransferase.人类碳水化合物硫酸转移酶和酪氨酰蛋白硫酸转移酶的组织特异性mRNA表达谱
Biol Pharm Bull. 2007 Apr;30(4):821-5. doi: 10.1248/bpb.30.821.
3
Tissue-specific mRNA expression profiles of human nuclear receptor subfamilies.人类核受体亚家族的组织特异性mRNA表达谱
Drug Metab Pharmacokinet. 2004 Apr;19(2):135-49. doi: 10.2133/dmpk.19.135.
4
Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies.人类ATP结合盒和溶质载体转运蛋白超家族的组织特异性mRNA表达谱
Drug Metab Pharmacokinet. 2005 Dec;20(6):452-77. doi: 10.2133/dmpk.20.452.
5
Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies.人类溶质载体转运蛋白超家族的组织特异性mRNA表达谱
Drug Metab Pharmacokinet. 2008;23(1):22-44. doi: 10.2133/dmpk.23.22.
6
Tissue-specific mRNA expression profiles of human solute carrier 35 transporters.人类溶质载体35转运蛋白的组织特异性mRNA表达谱
Drug Metab Pharmacokinet. 2009;24(1):91-9. doi: 10.2133/dmpk.24.91.
7
Tissue-specific mRNA expression profiles of drug-metabolizing enzymes and transporters in the cynomolgus monkey.食蟹猴中药物代谢酶和转运体的组织特异性mRNA表达谱。
Drug Metab Pharmacokinet. 2009;24(2):139-44. doi: 10.2133/dmpk.24.139.
8
Transcriptional profiling of genes induced in the livers of patients treated with carbamazepine.接受卡马西平治疗患者肝脏中诱导基因的转录谱分析。
Clin Pharmacol Ther. 2006 Nov;80(5):440-456. doi: 10.1016/j.clpt.2006.08.013.
9
Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.通过高灵敏度实时逆转录PCR评估人细胞色素P450同工型mRNA表达的组织分布。
Yakugaku Zasshi. 2003 May;123(5):369-75. doi: 10.1248/yakushi.123.369.
10
Gene array profiles of alcohol and aldehyde metabolizing enzymes in brains of C57BL/6 and DBA/2 mice.C57BL/6和DBA/2小鼠大脑中酒精和醛代谢酶的基因阵列图谱。
Alcohol Clin Exp Res. 2006 Oct;30(10):1659-69. doi: 10.1111/j.1530-0277.2006.00201.x.

引用本文的文献

1
Assessing Drug-Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption.使用基于生理学的药代动力学建模(PBPK)方法结合半机制吸收评估BCS 2类化合物BI 730357(维甲酸相关孤儿受体γ拮抗剂,贝武罗根)的药物相互作用和食物效应。
Pharmaceutics. 2025 Mar 1;17(3):314. doi: 10.3390/pharmaceutics17030314.
2
PBPK modeling: What is the role of CYP3A4 expression in the gastrointestinal tract to accurately predict first-pass metabolism?生理药代动力学(PBPK)建模:胃肠道中细胞色素P450 3A4(CYP3A4)表达在准确预测首过代谢中起什么作用?
CPT Pharmacometrics Syst Pharmacol. 2025 Jan;14(1):130-141. doi: 10.1002/psp4.13249. Epub 2024 Oct 2.
3
A Novel Biomonitoring Method to Detect Pyrethroid Metabolites in Saliva of Occupationally Exposed Workers as a Tool for Risk Assessment.一种用于检测职业暴露工人唾液中拟除虫菊酯代谢物的新型生物监测方法,作为风险评估工具。
Hum Ecol Risk Assess. 2024;30(3-4):269-288. doi: 10.1080/10807039.2024.2329625. Epub 2024 May 19.
4
Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children.基于生理学的药代动力学模型与体表面积标度法预测从成人到儿童的酪氨酸激酶抑制剂暴露量。
Cancer Chemother Pharmacol. 2024 Aug;94(2):297-310. doi: 10.1007/s00280-024-04678-0. Epub 2024 May 23.
5
Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict CYP3A-Mediated Drug Interaction between Saxagliptin and Nicardipine: Bridging Rat-to-Human Extrapolation.基于生理的药代动力学(PBPK)模型预测沙格列汀与尼卡地平之间由CYP3A介导的药物相互作用:跨越从大鼠到人类的外推
Pharmaceutics. 2024 Feb 16;16(2):280. doi: 10.3390/pharmaceutics16020280.
6
Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions.母乳中依泽替米贝浓度的测定及其在预测母乳喂养婴儿暴露量中的应用。
Clin Pharmacokinet. 2024 Mar;63(3):317-332. doi: 10.1007/s40262-023-01345-0. Epub 2024 Jan 26.
7
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism.与 SLCO1B1 基因多态性相关的匹伐他汀的基于生理学的药代动力学(PBPK)建模。
Arch Pharm Res. 2024 Feb;47(2):95-110. doi: 10.1007/s12272-023-01476-9. Epub 2023 Dec 30.
8
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling.最大似然估计法用于儿科 PBPK 模型中肾转运体个体发育曲线的构建。
CPT Pharmacometrics Syst Pharmacol. 2024 Apr;13(4):576-588. doi: 10.1002/psp4.13102. Epub 2024 Jan 10.
9
Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes.基于生理学的药代动力学(PBPK)模型预测不同 CYP2C9 基因型人群中厄贝沙坦的药代动力学。
Arch Pharm Res. 2023 Dec;46(11-12):939-953. doi: 10.1007/s12272-023-01472-z. Epub 2023 Dec 8.
10
Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for Vericiguat.应用基于生理学的药代动力学模型评估维立西呱的尿苷二磷酸葡萄糖醛酸基转移酶介导的药物相互作用。
CPT Pharmacometrics Syst Pharmacol. 2024 Jan;13(1):79-92. doi: 10.1002/psp4.13059. Epub 2023 Oct 12.